GO:0004797 thymidine kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004797 (thymidine kinase activity) catalyzes the ATP-dependent phosphorylation of thymidine to thymidine 5'-phosphate, the first step of the pyrimidine salvage pathway.
• Thymidine kinase activity is a key activator of nucleoside analog prodrugs used in oncology and antiviral therapy, since phosphorylation is required for drug activation.
• Loss of thymidine kinase activity confers resistance to thymidine-analog antibiotics and antivirals, as shown in thymidine kinase-deficient Staphylococcus aureus.
• Thymidine kinase activity is elevated in proliferating cells and is used as a serum biomarker of cellular proliferation in lymphoma.
• Thymidine kinase 1 (TK1) and deoxycytidine kinase (DCK) activities are modulated by oxidative stress such as hydrogen peroxide and by nucleoside analogs.
• Biosensor platforms now enable ultrasensitive, label-free detection of thymidine kinase activity for research and diagnostic applications.
Description
Thymidine kinase activity (GO:0004797) is a molecular function defined as the catalysis of the reaction ATP + thymidine = ADP + thymidine 5'-phosphate. This phosphorylation reaction is the rate-limiting first step of the pyrimidine salvage pathway, allowing cells to recycle thymidine into thymidine monophosphate for DNA synthesis. Because it controls the supply of thymidine nucleotides, thymidine kinase activity is tightly linked to cell proliferation and DNA replication. The enzyme is also clinically important because it activates nucleoside analog prodrugs, including antineoplastic and antiviral agents, by converting them to their phosphorylated forms. In antiretroviral-naive HIV-infected patients, thymidine kinase and deoxycytidine kinase activities in mononuclear cells have been measured to understand nucleoside analog metabolism. In veterinary oncology, serum thymidine kinase activity has been proposed as an alternative to histologic markers of cellular proliferation in canine lymphoma. More recently, nanochannel-based biosensors have been developed for ultrasensitive, label-free detection of thymidine kinase activity, highlighting its growing role as a measurable biomarker.
thymidine kinase activity At A Glance
| GO ID | GO:0004797 |
|---|---|
| GO term | thymidine kinase activity |
| Ontology | molecular_function |
| Synonym | 2'-deoxythymidine kinase activity; ATP:thymidine 5'-phosphotransferase activity; deoxythymidine kinase (phosphorylating); thymidine kinase (phosphorylating) |
| Major function | Catalysis of the reaction: ATP + thymidine = ADP + thymidine 5'-phosphate |
| Pathway | Pyrimidine salvage pathway |
| Substrates | ATP and thymidine |
| Products | ADP and thymidine 5'-phosphate |
| Cellular role | Provides thymidine nucleotides for DNA synthesis and activates nucleoside analog prodrugs |
What Is GO:0004797?
Thymidine kinase activity (GO:0004797) is the catalytic function that transfers a phosphate group from ATP to thymidine, producing ADP and thymidine 5'-phosphate. This activity is synonymous with 2'-deoxythymidine kinase activity, ATP:thymidine 5'-phosphotransferase activity, deoxythymidine kinase (phosphorylating), and thymidine kinase (phosphorylating). It belongs to the molecular_function ontology aspect and is essential for the salvage of thymidine into the nucleotide pool.
Why Is thymidine kinase activity Important in Cell Biology?
Thymidine kinase activity is important because it controls the first committed step of thymidine salvage and thus directly influences DNA precursor availability and cell proliferation. It is a critical activator of nucleoside analog drugs, and modulation of its activity can enhance or reduce drug efficacy. Loss of thymidine kinase activity is a known resistance mechanism in bacteria such as Staphylococcus aureus against thymidine-analog antibiotics. In HIV patients, measuring thymidine kinase and deoxycytidine kinase activity helps understand nucleoside analog metabolism and potential drug interactions. In cancer, serum thymidine kinase activity serves as a proliferation marker in lymphoma. The enzyme is also sensitive to oxidative stress and nucleoside analogs, making it a dynamic regulator of nucleotide homeostasis.
• Thymidine kinase activity is the rate-limiting step of the pyrimidine salvage pathway, supplying thymidine nucleotides for DNA replication.
• It activates antineoplastic and antiviral nucleoside analogs by phosphorylation, a prerequisite for their cytotoxic or antiviral effects.
• Thymidine kinase deficiency in Staphylococcus aureus reduces susceptibility to thymidine-analog antibiotics such as iclaprim.
• Serum thymidine kinase activity is a biomarker of cellular proliferation in canine lymphoma and potentially in human cancers.
• Thymidine kinase 1 and deoxycytidine kinase activities are modulated by hydrogen peroxide, linking oxidative stress to nucleotide metabolism.
• In antiretroviral-naive HIV-infected patients, thymidine kinase and deoxycytidine kinase activities in mononuclear cells are altered, affecting nucleoside analog drug activation.
• Thymidine kinase activity declines rapidly during differentiation of Naegleria, indicating a link to developmental state.
• Biosensors for thymidine kinase activity enable ultrasensitive detection for research and clinical diagnostics.
• Mammalian deoxyribonucleoside kinases, including thymidine kinase, are key enzymes in nucleoside salvage and drug metabolism.
• Modulation of thymidine kinase activity is a biochemical strategy to enhance activation of antineoplastic drugs.
Molecular Mechanism of thymidine kinase activity
Substrate binding and catalysis
In simple terms: Thymidine kinase grabs thymidine and ATP, then moves a phosphate from ATP onto thymidine.
Thymidine kinase activity catalyzes the transfer of the gamma-phosphate of ATP to the 5'-hydroxyl group of thymidine, yielding ADP and thymidine 5'-phosphate. This reaction is the first step in the pyrimidine salvage pathway and is essential for recycling thymidine into the nucleotide pool. The enzyme requires magnesium ions for catalysis, as is typical for kinases that use ATP as a phosphate donor.
Role in nucleoside analog activation
In simple terms: The same enzyme that phosphorylates thymidine also activates certain drugs by adding a phosphate to them.
Thymidine kinase activity is responsible for the initial phosphorylation of thymidine analog prodrugs, converting them into monophosphate forms that are further phosphorylated to active triphosphates. This activation is required for the antineoplastic and antiviral effects of drugs such as 5-fluorodeoxyuridine and zidovudine. Modulation of thymidine kinase activity can therefore enhance or diminish drug efficacy.
Regulation by oxidative stress and nucleoside analogs
In simple terms: Chemicals and stress can change how active thymidine kinase is.
The expression and activity of thymidine kinase 1 and deoxycytidine kinase are modulated by hydrogen peroxide and nucleoside analogs. This suggests that oxidative stress and drug exposure can alter thymidine salvage capacity. Such regulation may affect cellular sensitivity to nucleoside analog drugs.
Thymidine kinase deficiency and drug resistance
In simple terms: If the enzyme is missing, drugs that need it do not work.
Thymidine kinase-deficient Staphylococcus aureus shows reduced susceptibility to iclaprim, a thymidine-analog antibiotic, in a mouse protection model. This demonstrates that thymidine kinase activity is essential for the antibacterial activity of certain drugs. Loss of thymidine kinase activity is therefore a mechanism of drug resistance.
Thymidine kinase as a proliferation marker
In simple terms: More enzyme activity often means more cell division.
Serum thymidine kinase activity correlates with cellular proliferation and has been proposed as an alternative to histologic markers in canine lymphoma. In HIV-infected patients, thymidine kinase and deoxycytidine kinase activities in mononuclear cells are measured to assess nucleoside analog metabolism. These clinical applications highlight the value of thymidine kinase activity as a biomarker [2,8].
Key Genes Involved in GO:0004797 thymidine kinase activity
The following genes and proteins are directly associated with thymidine kinase activity or its regulation, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TK1 | Cytosolic thymidine kinase 1; phosphorylates thymidine in the salvage pathway | Modulated by hydrogen peroxide and nucleoside analogs; proliferation marker |
| TK2 | Mitochondrial thymidine kinase 2; phosphorylates thymidine for mitochondrial DNA synthesis | Mammalian deoxyribonucleoside kinase involved in nucleoside salvage |
| DCK | Deoxycytidine kinase; phosphorylates deoxycytidine and cytidine analogs | Activity modulated together with TK1 by hydrogen peroxide and nucleoside analogs |
| DGUOK | Deoxyguanosine kinase; phosphorylates deoxyguanosine | Mammalian deoxyribonucleoside kinase family member |
| RRM1 | Ribonucleotide reductase subunit M1; converts NDPs to dNDPs | Provides dNDP substrates for thymidine nucleotide synthesis |
| RRM2 | Ribonucleotide reductase subunit M2; converts NDPs to dNDPs | Provides dNDP substrates for thymidine nucleotide synthesis |
| TYMS | Thymidylate synthase; de novo synthesis of thymidylate | Complements salvage pathway; target of antineoplastic drugs |
| DPYD | Dihydropyrimidine dehydrogenase; degrades thymine and uracil | Affects thymidine availability and drug metabolism |
| SLC29A1 | Equilibrative nucleoside transporter 1; imports thymidine | Influences intracellular thymidine concentration for salvage |
| SLC28A1 | Concentrative nucleoside transporter 1; imports thymidine | Influences intracellular thymidine concentration for salvage |
| NME1 | Nucleoside diphosphate kinase 1; transfers phosphates | May indirectly affect nucleotide pools |
| NME2 | Nucleoside diphosphate kinase 2; transfers phosphates | May indirectly affect nucleotide pools |
| AK1 | Adenylate kinase 1; maintains ATP/ADP balance | Supports ATP supply for thymidine kinase reaction |
| AK2 | Adenylate kinase 2; maintains ATP/ADP balance | Supports ATP supply for thymidine kinase reaction |
| CDA | Cytidine deaminase; deaminates cytidine and analogs | Affects nucleoside analog metabolism |
| NT5C | 5'-nucleotidase, cytosolic; dephosphorylates nucleoside monophosphates | Regulates thymidine monophosphate levels |
| NT5E | 5'-nucleotidase, ecto; dephosphorylates extracellular nucleotides | Regulates extracellular thymidine levels |
| ENTPD1 | Ectonucleoside triphosphate diphosphohydrolase 1; hydrolyzes ATP | Modulates ATP availability for thymidine kinase |
How Is thymidine kinase activity Regulated?
Thymidine kinase activity is regulated at multiple levels. The expression and activity of thymidine kinase 1 and deoxycytidine kinase are modulated by hydrogen peroxide and nucleoside analogs, indicating redox and substrate-level regulation. In antiretroviral-naive HIV-infected patients, thymidine kinase and deoxycytidine kinase activities in mononuclear cells are altered, suggesting that viral infection and immune activation influence enzyme activity. Thymidine kinase activity declines rapidly during differentiation of Naegleria, linking its regulation to developmental programs. Additionally, modulation of thymidine kinase activity is a biochemical strategy to enhance the activation of antineoplastic drugs, implying that its activity can be pharmacologically manipulated.
thymidine kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TK1 | Cancer proliferation marker; drug activation | TK1 knockout and overexpression cell lines; serum TK1 assays [2,5] |
| TK2 | Mitochondrial DNA depletion syndromes | TK2 knockout cells; mitochondrial function assays |
| DCK | HIV therapy response; nucleoside analog metabolism | DCK knockout and overexpression in mononuclear cells [5,8] |
| TK (bacterial) | Antibiotic resistance to thymidine analogs | Thymidine kinase-deficient Staphylococcus aureus mouse protection model |
| TYMS | Chemotherapy response; thymidylate synthesis | TYMS knockout and point-mutation cell lines |
Cancer and cellular proliferation
Thymidine kinase activity is elevated in proliferating cells and is used as a serum biomarker of cellular proliferation in canine lymphoma. In oncology, thymidine kinase activity is required for the activation of antineoplastic nucleoside analogs, and modulating its activity can enhance drug efficacy. Therefore, thymidine kinase activity is both a proliferation marker and a determinant of chemotherapy response [2,4].
Bacterial infections and drug resistance
Thymidine kinase-deficient Staphylococcus aureus exhibits reduced susceptibility to iclaprim, a thymidine-analog antibiotic, in a mouse protection model. This demonstrates that loss of thymidine kinase activity is a mechanism of antibiotic resistance. Consequently, thymidine kinase activity is a potential target for developing new antibacterial strategies.
HIV infection and antiretroviral therapy
In antiretroviral-naive HIV-infected patients, thymidine kinase and deoxycytidine kinase activities in mononuclear cells are altered compared to uninfected controls. These enzymes are responsible for activating nucleoside analog reverse transcriptase inhibitors, so changes in their activity may affect drug efficacy and toxicity. Monitoring thymidine kinase activity could help optimize antiretroviral therapy.
Oxidative stress and nucleotide metabolism
Hydrogen peroxide modulates the expression and activity of thymidine kinase 1 and deoxycytidine kinase, linking oxidative stress to nucleotide metabolism. This regulation may contribute to cellular responses to oxidative damage and influence sensitivity to nucleoside analogs. Understanding this interplay is relevant for diseases involving oxidative stress, such as cancer and neurodegeneration.
From thymidine kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TK1 affect thymidine salvage and drug sensitivity? | TK1 knockout cell line |
| Does a specific point mutation in TK1 alter catalytic activity? | TK1 point-mutation knock-in cell line |
| Can tagged TK1 be used to track subcellular localization? | Tagged TK1 knock-in cell line |
| Does overexpression of TK1 increase proliferation and drug activation? | TK1 overexpression cell line |
| Does TK2 deficiency impair mitochondrial DNA synthesis? | TK2 knockout cell line |
| Does thymidine kinase deficiency confer antibiotic resistance? | Thymidine kinase-deficient Staphylococcus aureus |
How to Study the thymidine kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive kinase assay | Conversion of thymidine to thymidine 5'-phosphate | Quantifying enzyme activity in cell lysates |
| Nanochannel biosensor | Label-free detection of thymidine kinase activity | Ultrasensitive clinical diagnostics |
| qPCR | mRNA expression of TK1 and DCK | Assessing transcriptional regulation |
| Western blot | Protein levels of TK1 and DCK | Assessing post-translational regulation |
| MTT assay | Cell proliferation and viability | Linking thymidine kinase activity to proliferation |
| Drug sensitivity assay | IC50 of nucleoside analogs | Evaluating drug activation and resistance |
| Serum TK activity assay | Thymidine kinase activity in serum | Biomarker of proliferation in lymphoma |
| Mouse protection model | Survival after bacterial infection | Testing thymidine kinase-deficient bacteria |
Enzymatic activity assays
Thymidine kinase activity is commonly measured using radioactive or non-radioactive assays that detect the conversion of thymidine to thymidine 5'-phosphate. These assays are used to quantify enzyme activity in cell lysates and serum samples. They are essential for studying drug activation and resistance mechanisms.
Biosensor-based detection
Nanochannel-based biosensors have been developed for ultrasensitive and label-free detection of thymidine kinase activity. These platforms enable rapid and sensitive measurement of enzyme activity in complex biological samples. They are particularly useful for clinical diagnostics and high-throughput screening.
Expression analysis by qPCR and Western blot
The expression of thymidine kinase 1 and deoxycytidine kinase can be assessed by qPCR and Western blot to complement activity measurements. These methods reveal whether changes in activity are due to transcriptional or post-translational regulation. They are widely used in studies of nucleoside analog metabolism.
Cell proliferation and drug sensitivity assays
Thymidine kinase activity is linked to cell proliferation, so proliferation assays such as MTT or BrdU incorporation are used alongside activity measurements. Drug sensitivity assays with nucleoside analogs reveal the functional consequences of altered thymidine kinase activity. These assays are standard in cancer and antiviral research.
How CRISPR Can Be Used to Study GO:0004797 thymidine kinase activity
Knockout
CRISPR knockout of TK1 or TK2 can be used to eliminate thymidine kinase activity and study its role in nucleotide salvage, DNA synthesis, and drug activation. TK1 knockout cells are expected to show reduced phosphorylation of thymidine and increased sensitivity to de novo synthesis inhibitors. Such models are valuable for dissecting the contribution of salvage versus de novo pathways.
Point Mutation
CRISPR point mutation can introduce specific amino acid substitutions in the catalytic domain of thymidine kinase to assess their impact on enzyme activity and substrate specificity. These models help identify residues critical for ATP binding and catalysis. They are also useful for studying drug resistance mutations.
Knock-in
CRISPR knock-in can be used to add tags such as FLAG or GFP to endogenous thymidine kinase, enabling real-time tracking of its expression and localization. Tagged knock-in models facilitate studies of enzyme dynamics and interactions. They also allow for precise measurement of protein levels without overexpression artifacts.
Overexpression
CRISPR overexpression or cDNA-based overexpression of thymidine kinase can be used to increase enzyme activity and study its effects on proliferation and drug sensitivity. Overexpression models are useful for testing whether increased thymidine salvage enhances activation of nucleoside analog prodrugs. They can also reveal feedback regulation of nucleotide pools.
How EDITGENE Supports thymidine kinase activity Research
Researchers studying thymidine kinase activity-related genes often need to determine whether a candidate gene is causally involved in nucleotide metabolism, drug activation, or disease progression. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for thymidine kinase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TK1 Knockout HEK293 Cell Line | EDJ-KQ5934 | Human | 7083 | Details Get a Quote |
| TK2 Knockout HEK293 Cell Line | EDJ-KQ17908 | Human | 7084 | Details Get a Quote |
| TK2 Knockout A-549 Cell Line | EDJ-KQ25698 | Human | 7084 | Details Get a Quote |
| TK2 Knockout HCT 116 Cell Line | EDJ-KQ25699 | Human | 7084 | Details Get a Quote |
| TK2 Knockout HeLa Cell Line | EDJ-KQ25700 | Human | 7084 | Details Get a Quote |
| TK1 Knockout A-549 Cell Line | EDJ-KQ29480 | Human | 7083 | Details Get a Quote |
| TK1 Knockout HCT 116 Cell Line | EDJ-KQ29481 | Human | 7083 | Details Get a Quote |
| TK1 Knockout HeLa Cell Line | EDJ-KQ29482 | Human | 7083 | Details Get a Quote |
Displaying Records 1 To 8 Of 8 Records
Frequently Asked Questions About thymidine kinase activity
What is thymidine kinase activity?
Thymidine kinase activity (GO:0004797) is the catalysis of the reaction ATP + thymidine = ADP + thymidine 5'-phosphate, the first step of the pyrimidine salvage pathway.
What genes are involved in thymidine kinase activity?
Key genes include TK1, TK2, DCK, and DGUOK, which encode deoxyribonucleoside kinases that phosphorylate thymidine and related nucleosides.
What is the function of thymidine kinase in DNA synthesis?
Thymidine kinase provides thymidine 5'-phosphate for DNA synthesis by salvaging thymidine, complementing de novo synthesis by thymidylate synthase.
How is thymidine kinase activity measured?
It is measured by enzymatic assays that detect the conversion of thymidine to thymidine 5'-phosphate, or by ultrasensitive biosensors [1,6].
Why is thymidine kinase important in cancer?
Thymidine kinase activity is elevated in proliferating cells and is a serum biomarker in lymphoma; it also activates antineoplastic nucleoside analogs [2,4].
What diseases are associated with thymidine kinase deficiency?
Thymidine kinase deficiency in bacteria causes resistance to thymidine-analog antibiotics, and in humans TK2 mutations cause mitochondrial DNA depletion syndromes [3,6].
How does thymidine kinase activate antiviral drugs?
Thymidine kinase phosphorylates nucleoside analog prodrugs to their monophosphate forms, which are further phosphorylated to active triphosphates that inhibit viral replication [4,8].
Is thymidine kinase activity regulated by oxidative stress?
Yes, hydrogen peroxide modulates the expression and activity of thymidine kinase 1 and deoxycytidine kinase.
Can CRISPR be used to study thymidine kinase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect the role of thymidine kinase in nucleotide metabolism and drug response.
What is the clinical significance of serum thymidine kinase activity?
Serum thymidine kinase activity serves as a marker of cellular proliferation in canine lymphoma and is being explored as a biomarker in human cancers.
Conclusion
Thymidine kinase activity (GO:0004797) is a fundamental molecular function that links thymidine salvage to DNA synthesis and drug activation. Its dysregulation is implicated in cancer proliferation, bacterial antibiotic resistance, and HIV therapy response. Understanding its mechanism and regulation is essential for developing new therapeutic strategies. EDITGENE provides advanced CRISPR tools to create precise cell models for studying thymidine kinase activity in health and disease.
References
- 1. Rauf A et al.. 2024. Nanochannel-based biosensor for ultrasensitive and label-free detection of thymidine kinase activity.. Talanta 279:126626 PMID: 39116732
- 2. Madewell BR. 2004. Serum thymidine kinase activity: an alternative to histologic markers of cellular proliferation in canine lymphoma.. J Vet Intern Med 18(5):595-6 PMID: 15515571
- 3. Huang DB et al.. 2019. Iclaprim activity against wild-type and corresponding thymidine kinase-deficient Staphylococcus aureus in a mouse protection model.. Eur J Clin Microbiol Infect Dis 38(2):409-412 PMID: 30483998
- 4. Vázquez-Padua MA. 1994. Modulation of thymidine kinase activity: a biochemical strategy to enhance the activation of antineoplastic drugs.. P R Health Sci J 13(1):19-23 PMID: 8016290
- 5. Sun R et al.. 2020. The expression and activity of thymidine kinase 1 and deoxycytidine kinase are modulated by hydrogen peroxide and nucleoside analogs.. Nucleosides Nucleotides Nucleic Acids 39(10-12):1347-1358 PMID: 32189555
- 6. Arnér ES et al.. 1995. Mammalian deoxyribonucleoside kinases.. Pharmacol Ther 67(2):155-86 PMID: 7494863
- 7. Bols NC et al.. 1977. Rapid decline thymidine kinase activity during differentiation of Naegleria.. J Cell Physiol 90(2) PMID: 838776
- 8. Turriziani O et al.. 2005. Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients.. AIDS 19(5):473-9 PMID: 15764852
